These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Role for dopamine in malonate-induced damage in vivo in striatum and in vitro in mesencephalic cultures. Moy LY, Zeevalk GD, Sonsalla PK. J Neurochem; 2000 Apr; 74(4):1656-65. PubMed ID: 10737624 [Abstract] [Full Text] [Related]
5. Endogenous dopamine enhances the neurotoxicity of 3-nitropropionic acid in the striatum through the increase of mitochondrial respiratory inhibition and free radicals production. Villarán RF, Tomás-Camardiel M, de Pablos RM, Santiago M, Herrera AJ, Navarro A, Machado A, Cano J. Neurotoxicology; 2008 Mar; 29(2):244-58. PubMed ID: 18093658 [Abstract] [Full Text] [Related]
6. NMDA receptors modulate dopamine loss due to energy impairment in the substantia nigra but not striatum. Zeevalk GD, Manzino L, Sonsalla PK. Exp Neurol; 2000 Feb; 161(2):638-46. PubMed ID: 10686083 [Abstract] [Full Text] [Related]
12. Polychlorinated biphenyl-induced neurotoxicity in organotypic cocultures of developing rat ventral mesencephalon and striatum. Lyng GD, Snyder-Keller A, Seegal RF. Toxicol Sci; 2007 May; 97(1):128-39. PubMed ID: 17324953 [Abstract] [Full Text] [Related]
13. A novel systemically active caspase inhibitor attenuates the toxicities of MPTP, malonate, and 3NP in vivo. Yang L, Sugama S, Mischak RP, Kiaei M, Bizat N, Brouillet E, Joh TH, Beal MF. Neurobiol Dis; 2004 Nov; 17(2):250-9. PubMed ID: 15474362 [Abstract] [Full Text] [Related]
14. Dopamine mediates striatal malonate toxicity via dopamine transporter-dependent generation of reactive oxygen species and D2 but not D1 receptor activation. Xia XG, Schmidt N, Teismann P, Ferger B, Schulz JB. J Neurochem; 2001 Oct; 79(1):63-70. PubMed ID: 11595758 [Abstract] [Full Text] [Related]
15. Novel free radical spin traps protect against malonate and MPTP neurotoxicity. Matthews RT, Klivenyi P, Mueller G, Yang L, Wermer M, Thomas CE, Beal MF. Exp Neurol; 1999 May; 157(1):120-6. PubMed ID: 10222114 [Abstract] [Full Text] [Related]
17. Neuronal dopamine transporter activity, density and methamphetamine inhibition are differentially altered in the nucleus accumbens and striatum with no changes in glycosylation in rats behaviorally sensitized to methamphetamine. Bjorklund NL, Sorg BA, Schenk JO. Synapse; 2008 Oct; 62(10):736-45. PubMed ID: 18651643 [Abstract] [Full Text] [Related]
19. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively. Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK. J Neurosci; 2003 Nov 26; 23(34):10982-7. PubMed ID: 14645494 [Abstract] [Full Text] [Related]
20. In vivo vulnerability of dopamine neurons to inhibition of energy metabolism. Zeevalk GD, Manzino L, Hoppe J, Sonsalla P. Eur J Pharmacol; 1997 Feb 12; 320(2-3):111-9. PubMed ID: 9059843 [Abstract] [Full Text] [Related] Page: [Next] [New Search]